相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biosignatures of Exposure/Transmission and Immunity
Christopher L. King et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
Malaria vaccine clinical trials: what's on the horizon
Alberto Moreno et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Clinical profile of Plasmodium falciparum and Plasmodium vivax infections in low and unstable malaria transmission settings of Colombia
Myriam Arevalo-Herrera et al.
MALARIA JOURNAL (2015)
High prevalence of sub-microscopic infections in Colombia
Andres F. Vallejo et al.
MALARIA JOURNAL (2015)
Development of vaccines for Plasmodium vivax malaria
Ivo Mueller et al.
VACCINE (2015)
RTS,S Vaccination Is Associated With Serologic Evidence of Decreased Exposure to Plasmodium falciparum Liver- and Blood-Stage Parasites
Joe J. Campo et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis
Julia C. Cutts et al.
BMC MEDICINE (2014)
Asymptomatic malaria infections: detectability, transmissibility and public health relevance
Teun Bousema et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Plasmodium vivax Sporozoite Challenge in Malaria-Naive and Semi-Immune Colombian Volunteers
Myriam Arevalo-Herrera et al.
PLOS ONE (2014)
Sporozoite proteome analysis of Cryptosporidium parvum by one-dimensional SDS-PAGE and liquid chromatography tandem mass. spectrometry
Amam Zonaed Siddiki
JOURNAL OF VETERINARY SCIENCE (2013)
High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms
Fernanda G. Versiani et al.
MALARIA JOURNAL (2013)
Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis
Philip L. Felgner et al.
SCIENTIFIC REPORTS (2013)
Naturally Acquired Immune Responses to P. vivax Merozoite Surface Protein 3α and Merozoite Surface Protein 9 Are Associated with Reduced Risk of P. vivax Malaria in Young Papua New Guinean Children
Danielle I. Stanisic et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response
Sandipan Ray et al.
JOURNAL OF PROTEOMICS (2012)
The complexities of malaria disease manifestations with a focus on asymptomatic malaria
Dolie D. Laishram et al.
MALARIA JOURNAL (2012)
Phase I Safety and Immunogenicity Trial of Plasmodium vivax CS Derived Long Synthetic Peptides Adjuvanted with Montanide ISA 720 or Montanide ISA 51
Socrates Herrera et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Consistent Safety and Infectivity in Sporozoite Challenge Model of Plasmodium vivax in Malaria-Naive Human Volunteers
Socrates Herrera et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Sterile Protective Immunity to Malaria is Associated with a Panel of Novel P. falciparum Antigens
Angela Trieu et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Current status of Plasmodium vivax vaccine
Myriam Arevalo-Herrera et al.
HUMAN VACCINES (2010)
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray
Peter D. Crompton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Case Report: Successful Sporozoite Challenge Model in Human Volunteers with Plasmodium vivax Strain Derived from Human Donors
Socrates Herrera et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Acquired Immunity to Malaria
Denise L. Doolan et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams
Tim Hulsen et al.
BMC GENOMICS (2008)
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria
Faith H. A. Osier et al.
INFECTION AND IMMUNITY (2008)
Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
Yimin Wu et al.
PLOS ONE (2008)
Profiling humoral immune responses to P-falciparum infection with protein microarrays
Denise L. Doolan et al.
PROTEOMICS (2008)
A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1
PA Nogueira et al.
INFECTION AND IMMUNITY (2006)
Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 Pv200L:: A potential malaria vaccine subunit
A Valderrama-Aguirre et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2005)
Phase 1 vaccine trial of Pvs25H:: a transmission blocking vaccine for Plasmodium vivax malaria
EM Malkin et al.
VACCINE (2005)
Profiling the humoral immune response to infection by using proteome microarrays: High-throughput vaccine and diagnostic antigen discovery
DH Davies et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
